SG11201408490PA - Virus filtration of cell culture media - Google Patents
Virus filtration of cell culture mediaInfo
- Publication number
- SG11201408490PA SG11201408490PA SG11201408490PA SG11201408490PA SG11201408490PA SG 11201408490P A SG11201408490P A SG 11201408490PA SG 11201408490P A SG11201408490P A SG 11201408490PA SG 11201408490P A SG11201408490P A SG 11201408490PA SG 11201408490P A SG11201408490P A SG 11201408490PA
- Authority
- SG
- Singapore
- Prior art keywords
- cell culture
- international
- culture medium
- vienna
- filtration
- Prior art date
Links
- 239000006143 cell culture medium Substances 0.000 title abstract 7
- 238000011100 viral filtration Methods 0.000 title abstract 2
- 238000002360 preparation method Methods 0.000 abstract 6
- 241000700605 Viruses Species 0.000 abstract 3
- 238000001914 filtration Methods 0.000 abstract 3
- 238000000034 method Methods 0.000 abstract 3
- 239000000356 contaminant Substances 0.000 abstract 2
- 239000011148 porous material Substances 0.000 abstract 2
- 230000003612 virological effect Effects 0.000 abstract 2
- 238000004113 cell culture Methods 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 239000002537 cosmetic Substances 0.000 abstract 1
- 239000001963 growth medium Substances 0.000 abstract 1
- 230000008520 organization Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
- A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
- A61L2/0011—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using physical methods
- A61L2/0017—Filtration
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M29/00—Means for introduction, extraction or recirculation of materials, e.g. pumps
- C12M29/26—Conditioning fluids entering or exiting the reaction vessel
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M37/00—Means for sterilizing, maintaining sterile conditions or avoiding chemical or biological contamination
- C12M37/02—Filters
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/0018—Culture media for cell or tissue culture
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Sustainable Development (AREA)
- Cell Biology (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Cosmetics (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Separation Using Semi-Permeable Membranes (AREA)
- Filtering Materials (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261662814P | 2012-06-21 | 2012-06-21 | |
| PCT/US2013/045663 WO2013192009A1 (en) | 2012-06-21 | 2013-06-13 | Virus filtration of cell culture media |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201408490PA true SG11201408490PA (en) | 2015-01-29 |
Family
ID=48672845
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201408490PA SG11201408490PA (en) | 2012-06-21 | 2013-06-13 | Virus filtration of cell culture media |
| SG10201701721TA SG10201701721TA (en) | 2012-06-21 | 2013-06-13 | Virus filtration of cell culture media |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG10201701721TA SG10201701721TA (en) | 2012-06-21 | 2013-06-13 | Virus filtration of cell culture media |
Country Status (27)
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MY173835A (en) * | 2012-06-21 | 2020-02-24 | Baxter Int | Virus filtration of cell culture media |
| AR095196A1 (es) | 2013-03-15 | 2015-09-30 | Regeneron Pharma | Medio de cultivo celular libre de suero |
| SG10201507931QA (en) * | 2014-12-22 | 2016-07-28 | Emd Millipore Corp | Removal of microorganisms from cell culture media |
| WO2016154290A1 (en) * | 2015-03-23 | 2016-09-29 | Alexion Pharmaceuticals, Inc. | Virus filtration |
| EP3015542A1 (de) * | 2015-05-07 | 2016-05-04 | Bayer Technology Services GmbH | Modulare anlage und verfahren zur kontinuierlichen, keimreduzierten produktion und/oder aufbereitung eines produktes |
| TWI797060B (zh) | 2015-08-04 | 2023-04-01 | 美商再生元醫藥公司 | 補充牛磺酸之細胞培養基及用法 |
| US12157877B2 (en) * | 2016-04-15 | 2024-12-03 | Boehringer Ingelheim International Gmbh | Cell retention device and method |
| WO2018107099A1 (en) * | 2016-12-09 | 2018-06-14 | Lonza Ltd | Method for the reduction of viral titer in pharmaceuticals |
| SG11201912548XA (en) * | 2017-07-06 | 2020-01-30 | Regeneron Pharma | Cell culture process for making a glycoprotein |
| TW202505016A (zh) | 2018-05-04 | 2025-02-01 | 美商健臻公司 | 具有過濾系統的灌注式生物反應器 |
| BR112021017818A2 (pt) * | 2019-03-11 | 2022-03-22 | Genzyme Corp | Filtração viral tangencial |
| CN113825840A (zh) * | 2019-04-03 | 2021-12-21 | 建新公司 | 重组蛋白的连续生产 |
| US12297451B1 (en) | 2019-10-25 | 2025-05-13 | Regeneron Pharmaceuticals, Inc. | Cell culture medium |
| US20230181796A1 (en) * | 2020-05-14 | 2023-06-15 | North Carolina State University | Fast automated approach for the derivation of acellular extracellular matrix scaffolds from tissues |
| BR112023005657A2 (pt) * | 2020-10-02 | 2023-04-25 | Regeneron Pharma | Filtração retentiva contínua de vírus |
| WO2025019797A2 (en) * | 2023-07-19 | 2025-01-23 | Hatchless Inc. | System and method for low-cost sterilization of liquids |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0422874A (ja) * | 1990-05-16 | 1992-01-27 | Matsushita Electric Ind Co Ltd | 波形表示装置 |
| GB2352652A (en) * | 1999-08-06 | 2001-02-07 | Fsm Technologies Ltd | Pre-treating hollow fibre membranes for micro-organism detection |
| US6485686B1 (en) * | 1999-09-17 | 2002-11-26 | The United States Of America As Represented By The Secretary Of The Army | Method and apparatus for counting submicron sized particles |
| AU1811301A (en) | 1999-12-02 | 2001-06-12 | General Hospital Corporation, The | Methods for removal, purification, and concentration of viruses, and methods of therapy based thereupon |
| US6485688B1 (en) | 2000-04-24 | 2002-11-26 | General Electric Company | On-line sparging sampling and monitoring systems and methods |
| US6835311B2 (en) * | 2002-01-31 | 2004-12-28 | Koslow Technologies Corporation | Microporous filter media, filtration systems containing same, and methods of making and using |
| US6630016B2 (en) * | 2002-01-31 | 2003-10-07 | Koslow Technologies Corp. | Microporous filter media, filtration systems containing same, and methods of making and using |
| ES2214967B1 (es) * | 2003-03-06 | 2005-06-16 | Probitas Pharma, S.A | Procedimiento para la eliminacion de virus en soluciones de fibrinogeno y fibrinogeno obtenido por dicho procedimiento. |
| CN106916802B (zh) | 2003-12-01 | 2022-03-25 | 诺和诺德医疗保健公司 | 液体因子vii组合物的病毒过滤 |
| DE102005047301B4 (de) * | 2005-09-30 | 2009-04-16 | Sartorius Stedim Biotech Gmbh | Verfahren zum Nachweis der Virenabreicherung für die Validierung von Filtern und Filtrationsprozessen |
| US20070084788A1 (en) * | 2005-10-14 | 2007-04-19 | Millipore Corporation | Ultrafiltration membranes and methods of making and use of ultrafiltration membranes |
| US8309029B1 (en) * | 2009-03-26 | 2012-11-13 | The United States Of America As Represented By The Secretary Of The Army | Virus and particulate separation from solution |
| US8945895B2 (en) * | 2009-07-31 | 2015-02-03 | Baxter International Inc. | Methods of purifying recombinant ADAMTS13 and other proteins and compositions thereof |
| WO2011022657A1 (en) * | 2009-08-20 | 2011-02-24 | Baxter International Inc. | Purification of vwf for increased removal of non-lipid enveloped viruses |
| MY173835A (en) * | 2012-06-21 | 2020-02-24 | Baxter Int | Virus filtration of cell culture media |
-
2013
- 2013-06-13 MY MYPI2014003498A patent/MY173835A/en unknown
- 2013-06-13 EP EP16181886.9A patent/EP3103861B1/en active Active
- 2013-06-13 MY MYPI2018000283A patent/MY195362A/en unknown
- 2013-06-13 HU HUE13731015A patent/HUE031601T2/hu unknown
- 2013-06-13 EP EP13731015.7A patent/EP2732020B1/en active Active
- 2013-06-13 CA CA2876473A patent/CA2876473C/en active Active
- 2013-06-13 PL PL16181886.9T patent/PL3103861T3/pl unknown
- 2013-06-13 SG SG11201408490PA patent/SG11201408490PA/en unknown
- 2013-06-13 SI SI201330369A patent/SI2732020T1/sl unknown
- 2013-06-13 IN IN10441DEN2014 patent/IN2014DN10441A/en unknown
- 2013-06-13 KR KR1020157001269A patent/KR102008048B1/ko active Active
- 2013-06-13 MX MX2017005169A patent/MX386767B/es unknown
- 2013-06-13 PT PT161818869T patent/PT3103861T/pt unknown
- 2013-06-13 HR HRP20161435TT patent/HRP20161435T1/hr unknown
- 2013-06-13 DK DK16181886.9T patent/DK3103861T3/da active
- 2013-06-13 JP JP2015518459A patent/JP6220392B2/ja active Active
- 2013-06-13 EA EA201990887A patent/EA201990887A1/ru unknown
- 2013-06-13 AU AU2013277532A patent/AU2013277532B2/en active Active
- 2013-06-13 PL PL13731015T patent/PL2732020T3/pl unknown
- 2013-06-13 MX MX2014015950A patent/MX347319B/es active IP Right Grant
- 2013-06-13 ES ES13731015.7T patent/ES2601429T3/es active Active
- 2013-06-13 EA EA201590059A patent/EA033006B1/ru not_active IP Right Cessation
- 2013-06-13 BR BR112014031842-5A patent/BR112014031842B1/pt not_active IP Right Cessation
- 2013-06-13 KR KR1020197022413A patent/KR20190092618A/ko not_active Ceased
- 2013-06-13 DK DK13731015.7T patent/DK2732020T3/en active
- 2013-06-13 CN CN201810569534.4A patent/CN108795724A/zh active Pending
- 2013-06-13 NZ NZ629083A patent/NZ629083A/en unknown
- 2013-06-13 SG SG10201701721TA patent/SG10201701721TA/en unknown
- 2013-06-13 ES ES16181886T patent/ES2829968T3/es active Active
- 2013-06-13 CN CN201380032998.7A patent/CN104640969A/zh active Pending
- 2013-06-13 PT PT137310157T patent/PT2732020T/pt unknown
- 2013-06-13 WO PCT/US2013/045663 patent/WO2013192009A1/en active Application Filing
- 2013-06-19 US US13/921,417 patent/US9670456B2/en active Active
- 2013-06-19 TW TW106136343A patent/TWI698522B/zh active
- 2013-06-19 AR ARP130102198A patent/AR092847A1/es active IP Right Grant
- 2013-06-19 TW TW102121710A patent/TWI609962B/zh active
-
2014
- 2014-12-04 IL IL236073A patent/IL236073B/en active IP Right Grant
- 2014-12-15 ZA ZA2014/09253A patent/ZA201409253B/en unknown
- 2014-12-17 CO CO14277524A patent/CO7151484A2/es unknown
-
2017
- 2017-03-27 US US15/470,064 patent/US20170260498A1/en not_active Abandoned
- 2017-07-13 JP JP2017137031A patent/JP6557706B2/ja not_active Expired - Fee Related
- 2017-09-12 AU AU2017228547A patent/AU2017228547B2/en active Active
-
2018
- 2018-11-14 JP JP2018213613A patent/JP2019022526A/ja not_active Withdrawn
- 2018-12-04 IL IL263479A patent/IL263479B/en active IP Right Grant
-
2020
- 2020-03-12 US US16/816,641 patent/US11421202B2/en active Active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG11201408490PA (en) | Virus filtration of cell culture media | |
| SG11201408777WA (en) | Degradable filter for smoking articles | |
| SG11201408405WA (en) | Engineered three-dimensional connective tissue constructs and methods of making the same | |
| SG11201809912UA (en) | Hybrid carriers for nucleic acid cargo | |
| SG11201406903SA (en) | Cell culture compositions and methods for polypeptide production | |
| SG11201810628XA (en) | Nasal pharmaceutical compositions with a porous excipient | |
| SG11201407580YA (en) | Composition comprising two antibodies engineered to have reduced and increased effector function | |
| SG11201408251SA (en) | A pharmaceutical composition containing nicotinic acid and/or nicotinamide and/or tryptophan for positively influencing the intestinal microbiota | |
| SG11201407819UA (en) | Improved methods of cell culture for adoptive cell therapy | |
| SG11201407710VA (en) | Compositions comprising short-acting benzodiazepines | |
| SG11201407200TA (en) | Liquid formulation | |
| SG11201406987UA (en) | Glucokinase activator compositions for the treatment of diabetes | |
| SG11201805570WA (en) | Systems and methods for long term transdermal administration | |
| SG11201407340YA (en) | Treatment of myelosuppression | |
| SG11201408821SA (en) | Selective pi3k delta inhibitors | |
| SG11201908640TA (en) | Pyrrolidinones and a process to prepare them | |
| SG11201408092UA (en) | Endoprosthesis and delivery device for implanting such endoprosthesis | |
| SG11201408808WA (en) | Method and system for treatment of biological tissue | |
| SG11201408123SA (en) | Aminotriazolopyridine for use in the treatment of inflammation, and pharmaceutical compositions thereof | |
| SG11201901594RA (en) | Cell suspension for use in the treatment of lower extremity peripheral artery disease | |
| SG11201407680XA (en) | Membrane for filtrating water | |
| SG11201406787TA (en) | Rnai-based therapies for cardiomyopathies, muscular dystrophies and laminopathies | |
| SG11201408396QA (en) | Improved resid hydrotreating catalyst containing titania | |
| SG11201407405VA (en) | Method for identifying ligands of the ahr receptor having therapeutic sebosuppressive activity, and said ligands | |
| SG11201407800SA (en) | Selective binding of biological targets to solid phase ureides |